Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients

Seoul National University Hospital10 enrolled

Overview

Patients with pancreatic cancer often suffer from pain. Because of such a pain, their quality of life have seriously deteriorated. There have been a few studies that showed an effect for pain control by hyperthermia (heating the patient's body). However, there are several limitations in conventional hyperthermia. In this study, the investigators tried to show the effect of "Oncothermia" which is more selective to malignant tissue than conventional hyperthermia for pain control, increasing quality of life, and anti-tumor treatment.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cancer, Pancreas

Interventions

OncothermiaOTHER

Oncothermia is a kind of hyperthermia treatment. It serves heat energy more selectively than conventional hyperthermia.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Inoperable or recurred pancreatic ductal adenocarcinoma * After the each cycle of chemotherapy, the disease status was "stable disease" Exclusion Criteria: * Person who has an experience of hyperthermia treatment * Person who has a difficulty of sensing heat * Person who has a skin graft or breast reconstruction surgery * Person who has a cardiac pacemaker or an implanted metal * Pregnant or breast feeding women * Person with uncontrolled infection, diabetes, hypertension, ischemic heart disease, myocardial infarct within 6 months * Person who was treated with unproved drugs within 6 months * Person who have a serious disease which can affect the person's safety * Person who do not consent to the study

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

ECOG score change

Time frame: 3 months after oncothermia treatment

Secondary Outcomes

Progression free survival rate

Time frame: 3 months later after oncothermia treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.